When high-dose intravenous glucose is required, continuous intravenous infusion of glucagon as an additional therapy can help control hypoglycemia and prevent complications from fluid overload by reducing the rate of intravenous dextrose infusions required to prevent hypoglycemia [100]. This evidence concerns the gene GCG and Hypoglycemia.